Cargando…

Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production

Dihydroartemisinin (DHA), a natural product derived from the herbal medicine Artemisia annua, is recently used as a novel anti-cancer agent. However, some intrinsic disadvantages limit its potential for clinical management of cancer patients, such as poor water solubility and low bioavailability. No...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Yuanliang, Yang, Xiaoxin, Han, Ning, Liu, Yuanhong, Liang, Qiuju, Li, Liu-Gen, Hu, Jun, Li, Tong-Fei, Xu, Zhijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308639/ https://www.ncbi.nlm.nih.gov/pubmed/37386404 http://dx.doi.org/10.1186/s12951-023-01959-3

Ejemplares similares

Rincón de romos
por: Bullé-Goyri, Rafael, et al.
Publicado: (2022)

Drug metabolism-related gene ABCA1 augments temozolomide chemoresistance and immune infiltration abundance of M2 macrophages in glioma
por: Yan, Yuanliang, et al.
Publicado: (2023)

NR2F1 Regulates TGF-β1-Mediated Epithelial-Mesenchymal Transition Affecting Platinum Sensitivity and Immune Response in Ovarian Cancer
por: Liang, Qiuju, et al.
Publicado: (2022)

Rincón de Romos / Rafael Bullé-Goyri, Jorge Brash.
por: Bullé-Goyri, Rafael
Publicado: (2019)

Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer
por: Chen, Xi, et al.
Publicado: (2023)

Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response
por: Peng, Bi, et al.
Publicado: (2023)

High Expression of ROMO1 Aggravates the Malignancy of Hepatoblastoma
por: Lv, Jiangfeng, et al.
Publicado: (2021)

Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma
por: Yi, Qiaoli, et al.
Publicado: (2022)

A combined analysis of bulk and single-cell sequencing data reveals metabolic enzyme, pyruvate dehydrogenase E1 subunit beta (PDHB), as a prediction biomarker for the tumor immune response and immunotherapy
por: Zhang, Fan, et al.
Publicado: (2023)

Unraveling the significance of exosomal circRNAs in cancer therapeutic resistance
por: Kang, Fanhua, et al.
Publicado: (2023)

Relatos de don Jesús Ramos Romo: narración e historia personal /
por: Ramos Romo, Jesús, 1902-
Publicado: (1986)

Current insights into the functional roles of ferroptosis in musculoskeletal diseases and therapeutic implications
por: Zhang, Fan, et al.
Publicado: (2023)

Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities
por: Xu, Zhijie, et al.
Publicado: (2023)

Functional roles of magnetic nanoparticles for the identification of metastatic lymph nodes in cancer patients
por: Yan, Yuanliang, et al.
Publicado: (2023)

Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration
por: Yan, Yuanliang, et al.
Publicado: (2021)

Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer
por: Jo, Min Jee, et al.
Publicado: (2020)

Romo1 is involved in the immune response of glioblastoma by regulating the function of macrophages
por: Sun, Guan, et al.
Publicado: (2020)

Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker
por: Wang, Lei, et al.
Publicado: (2022)

Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors
por: Liang, Qiuju, et al.
Publicado: (2022)

The pharmaceutical death-ride of dihydroartemisinin
por: Jansen, Frans Herwig
Publicado: (2010)

Romo1 is a mitochondrial nonselective cation channel with viroporin-like characteristics
por: Lee, Gi Young, et al.
Publicado: (2018)

ROMO1 is required for mitochondrial metabolism during preimplantation embryo development in pigs
por: Zhou, Dongjie, et al.
Publicado: (2021)

FHOD1 is upregulated in glioma cells and attenuates ferroptosis of glioma cells by targeting HSPB1 signaling
por: Zhang, Fan, et al.
Publicado: (2023)

Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma
por: Ren, Xinxin, et al.
Publicado: (2021)

Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
por: Chen, Tao, et al.
Publicado: (2009)

Iron Promotes Dihydroartemisinin Cytotoxicity via ROS Production and Blockade of Autophagic Flux via Lysosomal Damage in Osteosarcoma
por: Shen, Ying, et al.
Publicado: (2020)

Resistance to Dihydroartemisinin
por: Cojean, Sandrine, et al.
Publicado: (2006)

Resistance to Dihydroartemisinin
por: Legrand, Eric, et al.
Publicado: (2007)

The Association of COVID-19 and Reactive Oxygen Species Modulator 1 (ROMO1) with Oxidative Stress
por: Amini, Mohammad Amin, et al.
Publicado: (2022)

Targeted Lipid Nanoparticles Encapsulating Dihydroartemisinin and Chloroquine Phosphate for Suppressing the Proliferation and Liver Metastasis of Colorectal Cancer
por: Peng, Jianqing, et al.
Publicado: (2021)

Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015)

Tumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death
por: LIU, JIA, et al.
Publicado: (2015)

ROMO1 is a constituent of the human presequence translocase required for YME1L protease import
por: Richter, Frank, et al.
Publicado: (2019)

Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients
por: Kim, Hong Jun, et al.
Publicado: (2017)

Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
por: Kong, Rui, et al.
Publicado: (2012)

Downregulated ADARB1 Facilitates Cell Proliferation, Invasion and has Effect on the Immune Regulation in Ovarian Cancer
por: Zhu, Wei, et al.
Publicado: (2021)

Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity
por: Wang, Zeng, et al.
Publicado: (2012)

Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study
por: Turan, Hasan, et al.
Publicado: (2022)

A covalent organic framework-based route to the in situ encapsulation of metal nanoparticles in N-rich hollow carbon spheres
por: Chen, Liyu, et al.
Publicado: (2016)

Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer
por: Hu, Kuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a7ahr4suh42s3n5qqe59tadjku